Back

Antiarrhythmic effect of 9-week hybrid cardiac telerehabilitation - subanalysis of the TELEREHabilitation in Heart Failure patients - TELEREH-HF randomized clinical trial.

23 April 2021 (14:00 - 21:00)
Organised by:
Congress Presentation Part of: ePoster session Lifestyle Modification EHRA Premium Access EHRA 2021

About the speaker

Photo
Professor Ewa Piotrowicz

National Institute of Cardiology, Warsaw Poland, Warsaw (Poland)

286 More presentations in this session

Presentation thumbnail
Non-valvular atrial fibrillation recurrence after sinus rhythm restoring at different follow-up periods: phenotype-genotype high-risk groups, considering rs10465885 polymorphism in connexin-40 gene
Doctor T. Mikhalieva (Kyiv, UA)
Abstract Slides
Presentation thumbnail
Atrial fibrillation substrate mapping with decrement evoked potential mapping.
Doctor O. Salvador (Parla, ES)
Abstract Slides
Presentation thumbnail
Atrial tissue characterization by cardiac magnetic resonance and high-density mapping in patients with atrial fibrillation
Miss R. Adelino Recasens (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Proarrhythmic atrial structural and molecular remodeling with advancing age. Implications for post-coronary artery bypass grafting atrial fibrillation occurrence.
Doctor R. SERBAN (Targu Mures, RO)
Abstract Slides
Presentation thumbnail
Find me if you can: lessons learned using the novel cartofinder algorithm in a routine workflow for catheter ablation of atrial fibrillation
Doctor C. Sohns (Bad Oeynhausen, DE)
Abstract Slides

Access the full session

Session thumbnail
ePoster session

The Event

Event poster

EHRA 2021

23 April 2021 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Hybrid telerehabilitation in patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction and preserved left ventricular ejection fraction-the randomised clinical trial
27 August 2021
thumbnail
Congress Presentation
Acute heart failure and in-hospital complex ventricular arrhythmogenesis. Can we predict its occurence?
14 March 2025
thumbnail
Congress Presentation
Cardiac rehabilitation and time to device detected atrial fibrillation recurrence: a longitudinal cohort study of patients with implanted cardiac devices
1 September 2025
thumbnail
Congress Presentation
Antiarrhythmic effect of Sacubitril-Valsartan: effects beyond reverse cardiac remodelling?
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources